Enabling faster therapeutic antibody discovery through an integrated AI/ML-wet lab platform

Описание к видео Enabling faster therapeutic antibody discovery through an integrated AI/ML-wet lab platform

During antibody discovery, researchers characterize and optimize thousands of antibody molecules to select ideal drug candidates. Artificial intelligence/machine learning (AI/ML) technologies provide new opportunities for identifying and generating high-quality antibody drugs in less time.

In this webinar, Charbel Eid, from BigHat Biosciences, will discuss an innovative AI/ML platform that guides antibody design and accelerates the discovery of better antibody therapeutics. Learn more at https://idtb.io/4xsnkb

Комментарии

Информация по комментариям в разработке